Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ezetimibe + simvastatin versus simvastatin alone in type 2 diabetes
2004-004525-99Phase 2Completed
- Sponsor
- Mario Negri Institute for Pharmacological Research
- Start
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in type 2 diabetes mellitus (T2DM), dyslipidemia, cardiac event risk and 1 more comparing Ezetimibe + simvastatin with Simvastatin alone (2 arms). Primary endpoint: Change in lipid profile. Started Jun 2005; status: completed.
02
Drugs
ezetimibesimvastatin
03
Conditions
type 2 diabetes mellitus (T2DM)dyslipidemiacardiac event risknephropathy
Beyond the preview
Go deeper on 2004-004525-99.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004525-99.